or Try an Advanced Search...

    Metastatic Melanoma Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 1.10
    AGEN F Agenus Inc. 16.78
    IOVA F Iovance Biotherapeutics, Inc. 3.76
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Melanoma Biopharmaceutical Cancer Cancer Treatment Clinical Medicine Medicine Adoptive Cell Transfer Alzheimer's Disease Antineoplastic Drugs Atrial Fibrillation Biopharmaceutical Products Biotechnology Breast And Lung Cancer Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cancer Vaccine Carcinoma Cell Therapy Checkpoint Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Metastatic Melanoma stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 8.89
    MEDX F Horizon Kinetics Medical ETF 6.23
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL A SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    RDIV A RevenueShares Ultra Dividend Fund 5.27
    View all Metastatic Melanoma ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to RDIV Compare MEDX to RDIV

        Metastatic Melanoma Stocks Recent News

        Date Stock Title
        Nov 24 BMY Bristol-Myers Squibb (NYSE:BMY) increases 4.7% this week, taking one-year gains to 24%
        Nov 22 BMY AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 IOVA 2 Innovative Stocks That Could Deliver Outsize Returns
        Nov 22 IOVA Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
        Nov 21 BMY Major companies that are also popular short-selling stocks
        Nov 21 BMY Is Bristol Myers Squibb Stock a Buy?
        Nov 21 BMY Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
        Nov 19 BMY Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
        Nov 19 AGEN Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
        Nov 18 BMY Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
        Nov 18 AGEN Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 18 BMY Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
        Nov 18 BMY EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Melanoma Biopharmaceutical Cancer Cancer Treatment Clinical Medicine Medicine Adoptive Cell Transfer Alzheimer's Disease Antineoplastic Drugs Atrial Fibrillation Biopharmaceutical Products Biotechnology Breast And Lung Cancer Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cancer Vaccine Carcinoma Cell Therapy Checkpoint Inhibitor
        Metastatic Melanoma

        Metastatic melanoma is a type of skin cancer that has spread to other parts of the body. It is the most advanced form of melanoma and is usually more difficult to treat than earlier stages of the disease. Metastatic melanoma can spread to the lymph nodes, lungs, liver, brain, and other organs. Treatment options may include surgery, radiation, chemotherapy, immunotherapy, and targeted therapy.

        Browse All Tags